VENLAFAXINE HYDROCHLORIDE (venlafaxine hydrochloride) by Bridge Therapeutics is 12. Approved for major depressive disorder (mdd), social anxiety disorder (sad), known and 1 more indications. First approved in 2019.
Drug data last refreshed 21h ago
12.1 Mechanism of Action The mechanism of the antidepressant action of venlafaxine in humans is believed to be associated with its potentiation of neurotransmitter activity in the CNS. Preclinical studies have shown that venlafaxine and its active metabolite, O-desmethylvenlafaxine (ODV), are…
Worked on VENLAFAXINE HYDROCHLORIDE at Bridge Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets
A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions